The Worldwide Breast Cancer Market – Competitive Analysis:
The Global Breast Cancer Market is well established market with number of companies operating in this market. There is large number of companies involved in the development of the products including the drugs, molecules. The Worldwide Breast Cancer Market is segmented on the basis of type into invasive ductal carcinoma, invasive lobular carcinoma and other. On the basis of treatment they are segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy and other. Chemotherapy is further segmented into antimetabolites, anthracyclines, taxanes and alkylating agents. Target therapy is further segmented into tyrosine kinase inhibitors and monoclonal antibodies Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others. On the basis of end users the market is segmented into hospital pharmacies, private pharmacies and other.
Breast cancer is the development of malign cell growth in the mammary tissue. The global breast cancer market is anticipated to generate a CAGR growth of 9.2% during review period of 2017 to 2023.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1379 .
Industry Drivers:
Growing incidence and prevalence coupled with the growing awareness about breast cancer are the critical drivers of the market. According to World Health Organization, breast cancer is the second most common type of cancer in women with approximately 200,000 new cases diagnosed worldwide per year. The shift of breast cancer towards the developing regions due to rise in risk factors such as obesity, exposure to radiation, alcohol, smoking and others is also charging the market. The growing income of women and growing concerns for women health are other drivers of the market. Growing governmental initiatives and support from social and health organizations are additional drivers.
The improving survival rates due to technological advancements are clinical driver of the market. For example, the 5-year survival rate for stage I breast cancer is close to 100% which falls to about 93% for stage II breast cancer.
Market Restraints:
Poor efficacy, effectiveness and adverse effects of present drug treatment are the critical restraints of the market. Although there has been a momentous improvement in the survival rates of stage I and II breast cancer the poor rates for stage III and IV are a deterrent to treatment. The 5-year survival rate for stage III and stage IV breast cancers is 72% and 22% respectively. The high cost of treatment, and the lack of healthcare infrastructure in underdeveloped economies of the world are other restraints on the market.
The report has been segmented by type, treatment, end users and regions to generate a comprehensive view of the market.
Breast Cancer Market Regional Analysis:
On regional basis, global breast cancer market is dominated by America. Changing lifestyle and increasing prevalence of breast cancer in America has driven the growth of the market. America breast cancer market is followed by Europe. Technological advances, increased life expectancy and healthcare expenditure of people is responsible for the growth of this market in America and Europe. Asia Pacific is expecting a fastest growth for the market.
Brest cancer is type of cancer developed in breast tissue. Formation of lump in a breast, red patches on the skin is the some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factor for developing breast cancer. According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compare with developing countries. Increasing number of females suffering from breast cancer is the major factor for the growth of market. Beside this adoption of unhealthy lifestyle, increasing female geriatric population, exposure to harmful radiation and increasing governmental initiatives also contributed in the growth of the market. As no absolute treatment is available there is a scope for developing the market across the world. While on other hand high cost of the treatment, adverse effects associated with the therapy and long approval time for the drugs are responsible for restraining the growth of the market.
The Global Breast Cancer Market is expected to grow at a CAGR of 9.2% during forecasted period 2017-2023. The Global Breast Cancer Market consist of players such as Pfizer (US), Novartis AG (Switzerland), Oncogenex (US), Apthera Inc (UK), BioNumerik Pharmaceuticals (US), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (US), Puma Biotechnology (US), Sanofi S.A. (US), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Genentech (US), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (US), Bristol-Myers Squibb company (US), Actavis, Inc. (US), Hospira, Inc. (US), and Bayer AG (Germany). These are some of the prominent players at the forefront of competition in the global breast cancer market.
Breast Cancer Market Segmentation:
Global breast cancer market is segmented on the basis of type into invasive ductal carcinoma, invasive lobular carcinoma and other. On the basis of treatment they are segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy and other. Chemotherapy is further segmented into antimetabolites, anthracyclines, taxanes and alkylating agents. Target therapy is further segmented into tyrosine kinase inhibitors and monoclonal antibodies Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others. On the basis of end users the market is segmented into hospital pharmacies, private pharmacies and other.
Get Discount @ https://www.marketresearchfuture.com/check-discount/1379 .
MAJOR TABLE OF CONTENTS Breast Cancer Market Research Report – Global Forecast To 2023:
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
TOC Continued….!
Ask Questions To Expertise @ https://www.marketresearchfuture.com/enquiry/1379 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/enquiry/1379